Kaohsiung Veterans General Hospital
Kaohsiung City, 813, Taiwan
NCT Number: NCT01138969
Proton Pump Inhibitors (PPI) can prevent the recurrence of peptic ulcer in clopidogrel users.
Looking for future studies?
Notify MeAll sexes
Interventional
Phase 2
Kaohsiung City, 813, Taiwan
The aim of the prospective, randomized study is to investigate the efficacy of PPI in prevention of ulcer recurrence for clopidogrel users. We plan to enroll 300 clopidogrel users without baseline gastroduodenal ulcer at initial endoscopy. The patients will be randomly assigned to receive either (1) esomeprazole (20 mg qd) plus clopidogrel or (2) clopidogrel treatment alone for 6 months. The ulcer recurrence rate between the treatment groups will be compared.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
esomeprazole 20 mg qd for 6 months
Other names: plavix
Time frame: 6 months
Number of participants with recurrent peptic ulcer within 6 months
Time frame: 6 months
participants with peptic ulcer bleeding within 6 months
Kaohsiung Veterans General Hospital.
Other
Efficacy of Proton Pump Inhibitor in Prevention of Clopidogrel-related Peptic Ulcer and Gastrointestinal Bleeding
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07123259
Colitis, Colitis, Ulcerative
Lahore, Pakistan
View Trial DetailsNCT05742568
Digestive System Diseases, Digestive System Neoplasms
Xi'an, Shaanxi, China
View Trial DetailsNCT00450658
Arthritis, Arthritis, Rheumatoid
View Trial DetailsNCT04784910
Digestive System Diseases, Duodenal Diseases
Seoul, South Korea
View Trial Details